Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

PPHE profits up despite art'hotel delays

(Sharecast News) - Hotels group PPHE posted a jump in half-yearly profits and held guidance despite supply chain issues holding up full openings of new art'hotel properties in London and Rome.

Earnings before interest, taxes, depreciation, and amortisation for the six months to June rose 6.7% to £48.3m as revenue hit a record £191m, up 6.1%. However, revenue per available room - a key industry metric - fell 2.2% to £107.8 as prices normalised after the Covid pandemic.

PPHE said soft openings at the art'otel Hoxton and Rome Piazza Sallustio properties "have been very well received by guests" and it still expected these properties to be meaningful contributors of at least £25m from next year.

Average room rates softened 4.4% on a like-for-like basis due to the market mix stabilising from the largely leisure driven performance of 2023, it added.

"While demand for leisure travel remained the most dominant business theme, as anticipated, the rate growth normalised in the first half of 2024, as leisure room rates moderated, and other market segments continued to increase," the company said.

"Corporate travel globally remained somewhat subdued but showed signs of building back towards pre-2019 levels. Nevertheless, forward booking momentum across all segments and geographies continued to be encouraging, with meetings and events performing particularly well, supporting longer-term forecasting."

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

Smith & Nephew appoints Ajay Dhankhar as chief corporate development & strategy officer
(Sharecast News) - Medical technology company Smith & Nephew said on Monday that it has appointed Ajay Dhankhar as chief corporate development & strategy officer with immediate effect.
Oxford Biomedica acquires last 10pc stake in US subsidiary
(Sharecast News) - Oxford Biomedica said on Monday it has acquired the remaining 10% stake in its US subsidiary, OXB US, from Q32 Bio, bringing its ownership of the business to 100% as previously planned.
PPHE acquiring prime London site for hotel development
(Sharecast News) - PPHE Hotel Group has announced the acquisition of a prime development site near the City of London, where it plans to build its first Radisson RED select service hotel in the capital.
Norcros to end tile production in South Africa
(Sharecast News) - Norcros announced on Monday that it will shut down manufacturing at Johnson Tiles South Africa at the end of June, following the conclusion of a strategic review.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.